Australia Updates Guidance on UDI Compliance Timeframes for Medical Devices
Australia’s Therapeutic Goods Administration (TGA) has updated its guidance on complying with Unique Device Identification (UDI) timeframes for medical devices, providing additional clarification on transitional arrangements and implementation expectations.
The guidance is intended to help sponsors and manufacturers understand Australia’s phased UDI implementation requirements and the applicable compliance timelines.
According to the TGA, the latest update published on 22 May 2026 includes:
clarification regarding existing devices
clarification on transitions from EU MDD to EU MDR and EU IVDD to EU IVDR
additional timeline graphics
new information relating to consignment stock
clarification of the definition of sponsor control
a compliance date summary
additional information concerning existing devices in Surgical Loan Kits (SLKs)
The guidance references the following legislative instruments:
Therapeutic Goods Legislation Amendment (Australian Unique Device Identification Database and Other Measures) Regulations 2025
Therapeutic Goods (Medical Devices) Regulations 2002
What this means for manufacturers
Manufacturers supplying devices to the Australian market should review the updated guidance carefully, particularly if they:
rely on EU MDR or IVDR transitional arrangements
manage consignment stock in Australia
supply legacy devices or Surgical Loan Kits
are preparing UDI implementation strategies across multiple jurisdictions
The additional clarification may impact internal compliance timelines, labelling updates, distributor coordination, and device data management processes.
The TGA also reiterates that this guidance focuses specifically on UDI compliance dates and transitional arrangements, while separate guidance covers the broader UDI requirements for labelling, packaging, and identifiers.
Manufacturers can access the official TGA guidance below.
